Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: Appearance mimicking leptomeningeal tumor dissemination

D. J. Rippe, O. B. Boyko, G. N. Fuller, H. S. Friedman, W. J. Oakes, S. C. Schold

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

The term gliomatosis cerebri was first used by Nevin in 1938 [1] and represents a neoplastic process of glial origin characterized by its diffuse pattern of infiltration along anatomic pathways [1, 2]. Radiologic methods of detecting gliomatosis cerebi have relied heavily on CT [3-6]. Recently, the efficacy of MR imaging in detecting this disease has been described [7, 8]. We report a case of histologically documented gliomatosis cerebri that on gadopentetate-dimeglumine-enhanced MR images exhibited an enhancement pattern that mimicked one that has been seen in children with leptomeningeal spread of primary intracranial neoplasms [9, 10]. In our case, examination of the CNS at autopsy demonstrated an absence of leptomeningeal tumor but provided a morphologic explanation for the appearance of the contrast-enhanced MR examination.

Original languageEnglish (US)
Pages (from-to)800-801
Number of pages2
JournalAmerican Journal of Neuroradiology
Volume11
Issue number4
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: Appearance mimicking leptomeningeal tumor dissemination'. Together they form a unique fingerprint.

  • Cite this

    Rippe, D. J., Boyko, O. B., Fuller, G. N., Friedman, H. S., Oakes, W. J., & Schold, S. C. (1990). Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: Appearance mimicking leptomeningeal tumor dissemination. American Journal of Neuroradiology, 11(4), 800-801.